NKMAX Co., Ltd.
Biotech firm for NK cell therapies, global research reagents, diagnostics, and supplements.
182400 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 돌마로 172 정자동, 헬스케어혁신파크 1층및6층, 성남시
- Website:
- https://nkmax.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
NKMAX Co., Ltd. is a biotechnology company specializing in technologies centered on Natural Killer (NK) cells. The company's operations span multiple segments, including the development of NK cell-based immunotherapies for cancer and other diseases. It is a key global manufacturer and supplier of high-quality research reagents, providing recombinant proteins and monoclonal antibodies to over 2,000 research institutions and diagnostic firms worldwide. Additionally, NKMAX offers a precision diagnostic test to quantify NK cell activity for immune function assessment and markets a line of dietary supplements, such as NK365, designed to support the immune system.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for NKMAX Co., Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-04 00:00 |
Legal Proceedings Report
회생절차종결결정
|
Korean | 8.5 KB | |
| 2025-09-03 00:00 |
Regulatory News Service
기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내 )
|
Korean | 3.2 KB | |
| 2025-08-25 00:00 |
Legal Proceedings Report
회생절차종결신청
|
Korean | 12.4 KB | |
| 2025-08-14 00:00 |
Board/Management Information
대표이사변경
|
Korean | 10.4 KB | |
| 2025-08-14 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 13.7 KB | |
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | |
| 2025-08-14 00:00 |
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
|
Korean | 13.6 KB | |
| 2025-08-13 00:00 |
Delisting Announcement
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내)
|
Korean | 3.1 KB | |
| 2025-08-12 00:00 |
Audit Report / Information
[기재정정]감사보고서제출 (2024사업연도)
|
Korean | 45.4 KB | |
| 2025-08-12 00:00 |
Audit Report / Information
[기재정정]감사보고서제출 (2023사업연도)
|
Korean | 29.1 KB | |
| 2025-08-12 00:00 |
Regulatory News Service
기타주요경영사항 (자본전액잠식등 사유 해소자료 제출)
|
Korean | 3.6 KB | |
| 2025-08-12 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 1.9 MB | |
| 2025-08-12 00:00 |
Delisting Announcement
기타시장안내 (감사의견 관련 형식적 상장폐지 사유 해소 및 매매거래정지 지속 안내)
|
Korean | 7.0 KB | |
| 2025-08-12 00:00 |
Delisting Announcement
주권매매거래정지기간변경 (상장폐지 사유 해소)
|
Korean | 5.0 KB | |
| 2025-08-12 00:00 |
Audit Report / Information
[기재정정]사업보고서 (2024.12)
|
Korean | 623.6 KB |
Automate Your Workflow. Get a real-time feed of all NKMAX Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for NKMAX Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
